Bharat Immunologicals (India) Financial Ratios

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 29.45  1.05  3.7%

Use fundamental data analysis to double-check all available reported financial drivers of Bharat Immunologicals to find out if markets are presently mispricing the company. We found twenty-two available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents . Use Bharat Immunologicals to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Bharat Immunologicals to be traded at 35.34 in 30 days

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with Reliance Industries, Tata Consultancy, Tata Consultancy, HDFC Bank, and HDFC BANK. Bharat Immunologicals Biologicals Corp Ltd offers oral polio vaccines diarrhea management kits for the management of diarrhea in young children zinc dispersible tablets and iron folic acid tablets for the treatment of iron deficiency and iron deficiency anemia. Bharat Immunologicals and Biologicals Corporationration Limited was founded in 1989 and is based in Bulandshahr India.

Bharat Immunologicals Return On Asset vs Debt to Equity

Bharat Immunologicals Biologicals Corp Ltd is rated below average in return on asset category among related companies. It is number one stock in debt to equity category among related companies .

Bharat Immunologicals Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Bharat Immunologicals correlated with the market. If Beta is less then 0 Bharat Immunologicals generally moves in the opposite direction as compared to the market. If Bharat Immunologicals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bharat Immunologicals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bharat Immunologicals is generally in the same direction as the market. If Beta > 1 Bharat Immunologicals moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 11% 

Chance of Financial Distress

Bharat Immunologicals Biologicals Corp Ltd has less than 11 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


Compare Bharat Immunologicals To Peers
U Singh  CFO

Opportunity Range

January 20, 2018 Opportunity Range